These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 30393160)

  • 1. Adipose tissue-derived mesenchymal stem cells cultured at high density express IFN-β and TRAIL and suppress the growth of H460 human lung cancer cells.
    Jung PY; Ryu H; Rhee KJ; Hwang S; Lee CG; Gwon SY; Kim J; Kim J; Yoo BS; Baik SK; Bae KS; Eom YW
    Cancer Lett; 2019 Jan; 440-441():202-210. PubMed ID: 30393160
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TRAIL-overexpressing Adipose Tissue-derived Mesenchymal Stem Cells Efficiently Inhibit Tumor Growth in an H460 Xenograft Model.
    Un Choi Y; Yoon Y; Jung PY; Hwang S; Hong JE; Kim WS; Sohn JH; Rhee KJ; Bae KS; Eom YW
    Cancer Genomics Proteomics; 2021; 18(4):569-578. PubMed ID: 34183389
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adipose Tissue-Derived Mesenchymal Stem Cells Suppress Growth of Huh7 Hepatocellular Carcinoma Cells via Interferon (IFN)-β-Mediated JAK/STAT1 Pathway
    Byun CS; Hwang S; Woo SH; Kim MY; Lee JS; Lee JI; Kong JH; Bae KS; Park IH; Kim SH; Eom YW
    Int J Med Sci; 2020; 17(5):609-619. PubMed ID: 32210710
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IFN-γ-primed human bone marrow mesenchymal stem cells induce tumor cell apoptosis in vitro via tumor necrosis factor-related apoptosis-inducing ligand.
    Du J; Zhou L; Chen X; Yan S; Ke M; Lu X; Wang Z; Yu W; Xiang AP
    Int J Biochem Cell Biol; 2012 Aug; 44(8):1305-14. PubMed ID: 22554587
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Claudin-7 suppresses the cytotoxicity of TRAIL-expressing mesenchymal stem cells in H460 human non-small cell lung cancer cells.
    Xia P; Wang W; Bai Y
    Apoptosis; 2014 Mar; 19(3):491-505. PubMed ID: 24242915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Activated human mesenchymal stem/stromal cells suppress metastatic features of MDA-MB-231 cells by secreting IFN-β.
    Yoon N; Park MS; Shigemoto T; Peltier G; Lee RH
    Cell Death Dis; 2016 Apr; 7(4):e2191. PubMed ID: 27077807
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Enhanced antitumor effect of combining interferon beta with TRAIL mediated by tumor-targeting adeno-associated virus vector on A549 lung cancer xenograft.
    Wang Y; He L; He G; Kong Y; Liu X; Cai H; Liu X; Tan W
    Sheng Wu Gong Cheng Xue Bao; 2010 Jun; 26(6):780-8. PubMed ID: 20815258
    [TBL] [Abstract][Full Text] [Related]  

  • 8. IFN-γ-secreting-mesenchymal stem cells exert an antitumor effect in vivo via the TRAIL pathway.
    Yang X; Du J; Xu X; Xu C; Song W
    J Immunol Res; 2014; 2014():318098. PubMed ID: 24971369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DNA-binding Cell-penetrating Peptide-based TRAIL Over-expression in Adipose Tissue-derived Mesenchymal Stem Cells Inhibits Glioma U251MG Growth.
    Shin J; Baik SK; Yoon Y; Hwang S; Sohn JH; Jo M; Kim WS; Rhee KJ; Whang K; Eom YW
    Anticancer Res; 2021 Jun; 41(6):2859-2866. PubMed ID: 34083276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytochalasin B-induced membrane vesicles from human mesenchymal stem cells overexpressing TRAIL, PTEN and IFN-β1 can kill carcinoma cancer cells.
    Chulpanova DS; Gilazieva ZE; Akhmetzyanova ER; Kletukhina SK; Rizvanov AA; Solovyeva VV
    Tissue Cell; 2021 Dec; 73():101664. PubMed ID: 34678531
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adipose tissue-derived mesenchymal stem cells cultured at high density express IFN-β and suppress the growth of MCF-7 human breast cancer cells.
    Ryu H; Oh JE; Rhee KJ; Baik SK; Kim J; Kang SJ; Sohn JH; Choi E; Shin HC; Kim YM; Kim HS; Bae KS; Eom YW
    Cancer Lett; 2014 Oct; 352(2):220-7. PubMed ID: 25016057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. M1 Macrophages Promote TRAIL Expression in Adipose Tissue-Derived Stem Cells, Which Suppresses Colitis-Associated Colon Cancer by Increasing Apoptosis of CD133
    Eom YW; Akter R; Li W; Lee S; Hwang S; Kim J; Cho MY
    Int J Mol Sci; 2020 May; 21(11):. PubMed ID: 32485960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro and in vivo discrepancy in inducing apoptosis by mesenchymal stromal cells delivering membrane-bound tumor necrosis factor-related apoptosis inducing ligand in osteosarcoma pre-clinical models.
    Guiho R; Biteau K; Grisendi G; Chatelais M; Brion R; Taurelle J; Renault S; Heymann D; Dominici M; Redini F
    Cytotherapy; 2018 Aug; 20(8):1037-1045. PubMed ID: 30093324
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Irradiation enhances the tumor tropism and therapeutic potential of tumor necrosis factor-related apoptosis-inducing ligand-secreting human umbilical cord blood-derived mesenchymal stem cells in glioma therapy.
    Kim SM; Oh JH; Park SA; Ryu CH; Lim JY; Kim DS; Chang JW; Oh W; Jeun SS
    Stem Cells; 2010 Dec; 28(12):2217-28. PubMed ID: 20945331
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antitumor effects of TRAIL-expressing mesenchymal stromal cells in a mouse xenograft model of human mesothelioma.
    Lathrop MJ; Sage EK; Macura SL; Brooks EM; Cruz F; Bonenfant NR; Sokocevic D; MacPherson MB; Beuschel SL; Dunaway CW; Shukla A; Janes SM; Steele C; Mossman BT; Weiss DJ
    Cancer Gene Ther; 2015 Jan; 22(1):44-54. PubMed ID: 25525034
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro anti-myeloma activity of TRAIL-expressing adipose-derived mesenchymal stem cells.
    Ciavarella S; Grisendi G; Dominici M; Tucci M; Brunetti O; Dammacco F; Silvestris F
    Br J Haematol; 2012 Jun; 157(5):586-98. PubMed ID: 22420897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mesenchymal Stem Cells Combined With IFNγ Induce Apoptosis of Breast Cancer Cells Partially Through TRAIL.
    Yenilmez EN; Genc D; Farooqi AA; Tunoglu S; Zeybek U; Akkoc T; Yaylim İ
    Anticancer Res; 2020 Oct; 40(10):5641-5647. PubMed ID: 32988888
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Adipose-derived mesenchymal stem cells as stable source of tumor necrosis factor-related apoptosis-inducing ligand delivery for cancer therapy.
    Grisendi G; Bussolari R; Cafarelli L; Petak I; Rasini V; Veronesi E; De Santis G; Spano C; Tagliazzucchi M; Barti-Juhasz H; Scarabelli L; Bambi F; Frassoldati A; Rossi G; Casali C; Morandi U; Horwitz EM; Paolucci P; Conte P; Dominici M
    Cancer Res; 2010 May; 70(9):3718-29. PubMed ID: 20388793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Gene therapy using TRAIL-secreting human umbilical cord blood-derived mesenchymal stem cells against intracranial glioma.
    Kim SM; Lim JY; Park SI; Jeong CH; Oh JH; Jeong M; Oh W; Park SH; Sung YC; Jeun SS
    Cancer Res; 2008 Dec; 68(23):9614-23. PubMed ID: 19047138
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dual-targeted antitumor effects against brainstem glioma by intravenous delivery of tumor necrosis factor-related, apoptosis-inducing, ligand-engineered human mesenchymal stem cells.
    Yang B; Wu X; Mao Y; Bao W; Gao L; Zhou P; Xie R; Zhou L; Zhu J
    Neurosurgery; 2009 Sep; 65(3):610-24; discussion 624. PubMed ID: 19687708
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.